SCHEMBL8639690

SCHEMBL8639690

CN(C)CCNC(=O)c1ccc([N+](=O)[O-])c(N(CCCl)CCCl)c1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 2/20 0.43
HPGD P15428 3/20 0.41
POLB P06746 2/20 0.41
GSTP1 P09211 1/20 0.41
GSTM2 P28161 1/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 2/20 0.40
LMNA P02545 1/20 0.39
ALDH1A1 P00352 6/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPK1 P28482 1/20 0.38
RAD52 P43351 2/20 0.36
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474447 0.81 SMN1; SMN2 (0.44) SMN1; SMN2HTTPOLBGSTP1GSTM2
SCHEMBL8636262 0.81 KMT2A (0.46) SMN1; SMN2HTTHPGDPOLBGSTP1
SCHEMBL8635142 0.80 GSTP1 (0.43) SMN1; SMN2HTTHPGDPOLBGSTP1
SCHEMBL8762030 0.80 MEN1 (0.62) SMN1; SMN2LMNAALDH1A1CYP2C19
SCHEMBL8636087 0.79 MAPT (0.51) SMN1; SMN2HTTHPGDPOLBGSTP1
SCHEMBL8760841 0.78 KMT2A (0.38) SMN1; SMN2POLBMAPTCYP1A2LMNA
SCHEMBL7476700 0.74 HTT (0.49) SMN1; SMN2HTTPOLBMAPTCYP1A2
SCHEMBL11554301 0.74 NPC1 (0.65) SMN1; SMN2HTTHPGDPOLBCYP1A2
SCHEMBL5822277 0.71 NPC1 (0.43) SMN1; SMN2HPGDPOLBCYP1A2LMNA
SCHEMBL3583472 0.70 KMT2A (0.44) SMN1; SMN2HTTHPGDMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750782-A ANTICARCINOGENIC AGENTS, ANTIHYPOXIC AGENTS, PRODRUGS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-05-12 US disclosed
EP-0616609-B1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RES CAMPAIGN TECH (GB) 1997-06-18 EP disclosed
US-5571845-A Nitroaniline derivatives and their use as anti-tumour agents CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-11-05 US disclosed
WO-1993011099-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1993-06-10 WO disclosed